Jilin Province Huinan Changlong Bio-pharmacy Company Limited
Research Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK) on Bullrun: market cap HKD 1.39B, P/E 5.6, dividend yield 11.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker8049.HK
- ExchangeHK
- CountryHong Kong
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyHKD
- Market capHKD 1.39B
- P/E5.6
- Dividend yield11.6%
- Financial periodFY2025
- RevenueCNY 901.87M
- Revenue growth2.4%
- Net incomeCNY 198.88M
- Free cash flowCNY 300.80M
- Gross margin84.0%
Valuation Snapshot
latest market cap is HKD 1.39B; P/E is 5.6; dividend yield is 11.6%.
Peer valuation comparison
Latest P/E is 5.64x versus a Healthcare sector median of 21.69x (74.0% below).
Latest dividend yield is 11.58% versus a Healthcare sector median of 2.41% (380.5% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 901.87M | CNY 198.88M | CNY 300.80M | 84.0% | 0.36 | CNY 143.10M | CNY 400.00K | CNY 1.69B |
| FY2024 | CNY 881.16M | CNY 184.25M | CNY 208.63M | 77.8% | 0.33 | CNY 235.85M | CNY 72.40M | CNY 1.63B |
| FY2023 | CNY 841.55M | CNY 148.21M | CNY 284.11M | 69.4% | 0.26 | CNY 352.14M | CNY 80.40M | CNY 1.48B |
| FY2022 | CNY 841.59M | CNY 193.57M | CNY 192.68M | 77.0% | 0.35 | CNY 113.60M | CNY 400.00K | CNY 1.61B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 1.39B | 5.6 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD, yield 11.6%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.27 CNY |
| FY2024 | 0.07 CNY |
| FY2023 | 0.55 CNY |
| FY2022 | 0.07 CNY |
| FY2021 | 0.07 CNY |
About Jilin Province Huinan Changlong Bio-pharmacy Company Limited
Jilin Province Huinan Changlong Bio-pharmacy Company Limited manufactures and distributes Chinese medicines and pharmaceutical products under the Changlong and Qing Tong brands in the People's Republic of China. The company provides Edaravone injection, compound brain comfort capsules, haikun kidney capsules, cefpirome sulfate for injections, Cefpiramide for injections, anti-bone hyperplasia tablets, Lysine zinc gluconate tablets, and Qianlie Guihuang Tablets.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Jilin Province Huinan Changlong Bio-pharmacy Company Limited's market cap?
Jilin Province Huinan Changlong Bio-pharmacy Company Limited's market capitalization is HKD 1.39B.
What is Jilin Province Huinan Changlong Bio-pharmacy Company Limited's P/E ratio?
Jilin Province Huinan Changlong Bio-pharmacy Company Limited's price-to-earnings (P/E) ratio is 5.6.
Does Jilin Province Huinan Changlong Bio-pharmacy Company Limited pay a dividend?
Jilin Province Huinan Changlong Bio-pharmacy Company Limited has a dividend yield of 11.6%.
What does Jilin Province Huinan Changlong Bio-pharmacy Company Limited do?
Jilin Province Huinan Changlong Bio-pharmacy Company Limited manufactures and distributes Chinese medicines and pharmaceutical products under the Changlong and Qing Tong brands in the People's Republic of China. The company provides Edaravone injection, compound brain comfort capsules, haikun kidney capsules, cefpirome sulfate for injections, Cefpiramide for injections, anti-bone hyperplasia tablets, Lysine zinc gluconate tablets, and Qianlie Guihuang Tablets. It also engages in the manufacture and distribution of beverages and prepackaged food, as well as health products.